Moonwalk Biosciences Stock

www.moonwalk.bioHealthcare / BioTech & PharmaFounded: 2022

Moonwalk Biosciences is an epigenetic medicine company with a specialization in genomic therapeutics. To enable healthcare providers with new therapies for patient treatment, the company’s mission is to use artificial intelligence prediction in its engineering platform to develop precise epigenetic medicine. Moonwalk Biosciences was founded by Alex Aravanis in 2022 and is headquartered in San Francisco, CA.

Register To Buy and Sell Shares

For more details on financing and valuation for Moonwalk Biosciences, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Moonwalk Biosciences’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Moonwalk Biosciences.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Arash Jamshidi Ph.D
Co-Founder, Chief Technology Officer & President
Justin Valley Ph.D
Co-Founder & Chief Operating Officer
Elaine Cheung
Chief Business Officer
Alexander Aravanis Ph.D
Co-Founder & Chief Executive Officer

Moonwalk Biosciences’ stock FAQs


Can you buy Moonwalk Biosciences’ stock?

Moonwalk Biosciences is not publicly traded on NYSE or NASDAQ in the U.S. To buy Moonwalk Biosciences’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Moonwalk Biosciences’ stock?

Yes, you can sell stock of a private company like Moonwalk Biosciences. Forge can help you sell your Moonwalk Biosciences stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Moonwalk Biosciences’ stock price?

Moonwalk Biosciences is a privately held company and therefore does not have a public stock price. However, you may access Moonwalk Biosciences’ private market stock price with Forge Data.

What is Moonwalk Biosciences’ stock ticker symbol?

Moonwalk Biosciences does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Moonwalk Bio Grabs $57 Million, Joins Push for ‘Epigenetic’ Treatments

Biotechnology startup Moonwalk Biosciences has raised $57 million in venture capital and joined a push to treat diseases through drugs that activate or suppress genes. Proponents say this new twist on genetic medicine, “epigenetic editing,” promises to lead to treatments or cures for a variety of common medical scourges, such as cancer and chronic hepatitis B.
Updated on: Jun 24, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.